Enhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and In Vitro Biological Assessment

• Kiana Bahremand,
• Faranak Aghaz,
• Kiumars Bahrami

Affiliations

Kiana Bahremand

Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

Faranak Aghaz

Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

Kiumars Bahrami

Nanoscience and Nanotechnology Research Center (NNRC), Razi University, Kermanshah, Iran